21 Sep 2020
Precision Medicine Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2020-2025. The growth in the precision medicine market is propelled by an increasing demand for personalized treatment; technological innovation and advancement , as well as growth of personal healthcare devices are major key factor which drives the Global Precision Medicine Market.
The key drivers for Global Precision Medicine Market are improvement in personal healthcare, latest wireless technologies with portable healthcare devices and upsurge in genetic diseases due to mutation, UV rays among others.Also growing approval of drug along with its diagnostic assay, cheaper profiling of DNA, rising rate of various types of cancer are some of the reasons leading to the growth of the Global Precision Medicine Market.The keypurpose of these regulations is to make precision medicines more acceptable and focused to genetic diseases associated to Oncology, skin, respiratory, CNS, CVD and infectious diseases among others. The patients are profitedultimately by these regulations as it save time and cutting cost as the patients acquire the vital treatment for the specific disease.Now, the Global Precision Medicine Market is ahead due to the growth of personal healthcare devices like Nebulizer, Infusion Pump, Glucose Meter and integration of smart technologies in the healthcare system such as Digital Patient Room Whiteboards. In addition, growing associations and partnerships between various ecosystem players are supporting the healthy growth of the Global Precision Medicine Market. The Global Precision Medicine Market is driven by rising demand for personalized treatment, technological advancement.
Geographically, North America is leading the share in Global Precision Medicine Market
Abbott headquarter in Abbott Park, Illinois and specialties in Nutrition, Diagnostics, Medical Devices, and Branded Generic Pharmaceuticals.
Abbott is creating LIFE-CHANGING TECHNOLOGY and a global healthcare leader that helps people live more fully at the stage of life.
Trump administration to purchase 150 million Abbott COVID-19 tests for $750 mln. WASHINGTON, Aug 27 The Trump administration will purchase 150 million rapid coronavirus tests from Abbott Laboratories for about $750 million, a White House spokeswoman said
NanoString Technologies, Inc. was established in 2003 and headquarter in Seattle, WA.
Specialties in Gene Expression, miRNA, CNV and Single Cell Analysis, Digital Genomics for Pathway-based Research, Multiplexed Molecular Diagnostic Development, General Purpose Reagents for Laboratory Use, and Translational Cancer Genomics and Cancer Research
NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research. The company's technology enables a wide variety of basic research and translational medicine applications.
NANOSTRING TECHNOLOGIES INC Quarterly Service AND Product REVENUE OF $24.5 MILLION, 15% GROWTH
Pfizer was established in 1848 and headquarter in New York
Specialties in To apply science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe and effective and affordable medicines and health care services to the people who need them.
Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives
News: Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial
Johnson & Johnson was established in 1887 and headquarter in New Brunswick, NJ
Specialties in Health Care, Medical Devices & Diagnostics, Pharmaceuticals, and Consumer
Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have been for the last 130 years.
News: Johnson & Johnson told to pay $2.1 billion over cancer-causing talc powder. Last month the firm announced it was discontinuing production of its talc-based baby powder in the US and Canada.
GE Healthcare established in 1892 and headquarter in Chicago
Specialties in Healthcare and Biotechnology
GE Healthcare is a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.
News: GE Healthcare said it would partner with five start-ups for Edison, its artificial intelligence-based healthcare platform.
Key Benefits –
Global Precision Medicine Market report covers in depth historical and forecast analysis.
Global Precision Medicine Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
The global report helps to identify opportunities in market place.
Global report covers an extensive analysis of emerging trends and competitive landscape and Comapny profile of Top Precision Medicine Companies.